This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.
Biomolecules, 14(3)
Citation
Al Musaimi, Othman. (2024). Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.. Biomolecules, 14(3). https://doi.org/10.3390/biom14030264